Amgen's TrumpRx Discounts and Dividend Hike Might Change The Case For Investing In Amgen (AMGN) [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
drugs such as Amjevita, Aimovig, and Repatha, while also preparing for its March 11 presentation at the Leerink Global Healthcare Conference in Miami. Together with its recently reported double-digit revenue and EPS growth in 2025 and progress in obesity and oncology programs, these moves highlight Amgen's focus on expanding access to its therapies while reinforcing its innovation-led rare disease and cardiovascular franchises. We'll now examine how Amgen's decision to discount key therapies through TrumpRx could influence its existing investment narrative around growth and margins. The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it . Find the list for free. Amgen Investment Narrative Recap To own Amgen, you need to believe its diversified portfolio and late-stage pipeline can offset pricing pressure, biosimilar competition, and heavier R&D and capex. The TrumpRx discounting move fits the e
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Amgen Inc. (AMGN): Billionaire Ken Fisher Doubles Bullish Position [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (AMGN) Collaborates on Ending Anti-OX40 Clinical Studies [Yahoo! Finance]Yahoo! Finance
- Amgen and GSK said to be adding products on TrumpRx [Seeking Alpha]Seeking Alpha
- 4 Biotech Stocks to Watch for Potential Upside in 2026 [Yahoo! Finance]Yahoo! Finance
- Two major drug companies are the latest to join TrumpRx [FOX Business Network]FOX Business Network
AMGN
Earnings
- 2/3/26 - Beat
AMGN
Sec Filings
- 3/6/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- AMGN's page on the SEC website